Pro-apoptotic signaling pathway

Pro-apoptotic pathways are highly regulated signaling networks that orchestrate programmed cell death, a fundamental process required for embryonic development, tissue homeostasis, and the elimination of damaged or infected cells (Elmore, 2007). These pathways are broadly categorized into the intrinsic (mitochondrial) pathway, which responds to internal cellular stresses like DNA damage, and the extrinsic (death receptor) pathway, which is triggered by external ligands binding to cell surface receptors (Jan & Chaudhry, 2019). In many diseases, particularly cancer, these pathways are frequently suppressed through the overexpression of anti-apoptotic proteins or the loss of pro-apoptotic factors, allowing malignant cells to survive and proliferate uncontrollably (D'Arcy, 2019). Therapeutic intervention often involves the use of BH3 mimetics, such as Venetoclax, which inhibit anti-apoptotic BCL-2 family members to restore the cell's natural ability to undergo apoptosis (Czabotar et al., 2014). While highly effective in certain hematologic malignancies, the systemic activation of pro-apoptotic signaling can lead to significant toxicities, including cytopenias and tumor lysis syndrome, necessitating careful patient monitoring and dose titration (NIH, 2023). Understanding the balance between pro- and anti-apoptotic signals remains a cornerstone of modern oncology and drug development.

Other names

Apoptosis pathwayProgrammed cell death pathwayIntrinsic apoptosis pathwayExtrinsic apoptosis pathwayApoptotic signaling cascade

Drugs targeting these pathways primarily function by inhibiting anti-apoptotic proteins like BCL-2 to lower the threshold for mitochondrial outer membrane permeabilization (MOMP) or by activating death receptors (e.g., TRAIL receptors) to directly initiate the caspase cascade (Elmore, 2007; Czabotar et al., 2014).